4
Changes in Ownership
Prime Medicine, Inc. Filed Acc 0001894562-25-000042
Options or other derivatives
- See Remarks acquired 203,333 shares (grant or award)
- See Remarks returned 203,333 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Alenson Carman See Remarks | 2025-08-01 | Returned to the company · Stock Option (right to buy) | −16,083 | 0 | D | ||
| Alenson Carman See Remarks | 2025-08-01 | Grant or award · Stock Option (right to buy) | +16,083 | 16,083 | D | ||
| Alenson Carman See Remarks | 2025-08-01 | Returned to the company · Stock Option (right to buy) | −90,498 | 0 | D | ||
| Alenson Carman See Remarks | 2025-08-01 | Grant or award · Stock Option (right to buy) | +90,498 | 90,498 | D | ||
| Alenson Carman See Remarks | 2025-08-01 | Returned to the company · Stock Option (right to buy) | −6,254 | 0 | D | ||
| Alenson Carman See Remarks | 2025-08-01 | Grant or award · Stock Option (right to buy) | +6,254 | 6,254 | D | ||
| Alenson Carman See Remarks | 2025-08-01 | Returned to the company · Stock Option (right to buy) | −90,498 | 0 | D | ||
| Alenson Carman See Remarks | 2025-08-01 | Grant or award · Stock Option (right to buy) | +90,498 | 90,498 | D | ||
Loading xslF345X05/wk-form4_1754440946.xml…